Finance News – Pharmaceutical
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Live: Trump's pharmaceutical tariff threat causing uncertainty
The proposed 200 percent tariff on pharmaceutical exports by the US administration is creating financial uncertainty for Australian drug manufacturers and potentially impacting int...
Read Full Article →Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
The termination of the collaboration between Hims & Hers and Novo Nordisk triggered a substantial decline in Hims & Hers’ share value, reflecting investor concerns about the compan...
Read Full Article →A $250 mistake seems set to cost Ozempic maker Novo Nordisk billions
Novo Nordisk is expected to face substantial financial losses as Canada prepares to introduce generic alternatives of its weight loss medication due to the company’s failure to mai...
Read Full Article →Novo Nordisk CEO steps down amid growing competition for weight loss drugs
The departure of the longstanding CEO coincides with increased market challenges in the weight management sector, potentially impacting the company's strategic direction and future...
Read Full Article →Novo Nordisk CEO to step down as Wegovy maker faces growing competition
The departure of the CEO at the Danish pharmaceutical company is expected to impact investor confidence as the firm navigates increased market rivalry and aims to sustain its finan...
Read Full Article →Trump says pharmaceutical tariffs are coming. Here's what to expect
The introduction of new tariffs on pharmaceutical products could potentially impact medication prices and affect the costs faced by both manufacturers and consumers in the healthca...
Read Full Article →Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Pharmaceutical companies are responding to potential tariff concerns by increasing their manufacturing investments in the U.S., indicating a strategic shift in their financial plan...
Read Full Article →